Exelon (EXC) director granted 3,720 RSUs, holds 10,013 phantom units
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Cheshire Marjorie Rodgers reported acquisition or exercise transactions in this Form 4 filing.
Exelon Corp director Marjorie Rodgers reported routine equity-based compensation and existing deferred balances. On 2026-04-28, she received a grant of 3,720 "2026 Directors Restricted Stock Units" under the Exelon Long-term Incentive Plan. These RSUs will fully vest and be settled in Exelon common stock on a 1-for-1 basis on 2027-04-28, and will also accrue additional stock units through dividend reinvestment that vest with the underlying award.
Rodgers also reported 10,013 deferred phantom share equivalents tied to Exelon common stock in a non-qualified deferred compensation plan. These phantom share equivalents are settled in cash on a 1-for-1 basis when her service on the board ends. No open-market purchases or sales were reported in this filing.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Cheshire Marjorie Rodgers
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | 2026 Directors Restricted Stock Units | 3,720 | $0.00 | -- |
| holding | Deferred phantom share equivalents | -- | -- | -- |
Holdings After Transaction:
2026 Directors Restricted Stock Units — 3,720 shares (Direct, null);
Deferred phantom share equivalents — 10,013 shares (Direct, null)
Footnotes (1)
- Annual restricted stock unit (RSU) award subject to the Exelon Long-term Incentive Plan (LTIP) will fully vest and be settled in shares of Exelon common stock on a 1 for 1 basis. The award will accrue additional stock units through dividend reinvestment which will vest along with the underlying award. Phantom share equivalents held in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan. Phantom share equivalents will be settled for cash on a 1 for 1 basis upon the termination of the reporting person's service to the board of directors.
Key Figures
2026 director RSU grant: 3,720 units
RSU vesting and settlement date: April 28, 2027
Deferred phantom share equivalents: 10,013 units
+1 more
4 metrics
2026 director RSU grant
3,720 units
Grant of 2026 Directors Restricted Stock Units on April 28, 2026
RSU vesting and settlement date
April 28, 2027
RSUs vest and settle 1-for-1 in Exelon common stock
Deferred phantom share equivalents
10,013 units
Deferred phantom share equivalents tied to Exelon common stock
Phantom equivalent settlement basis
1-for-1 in cash
Cash settlement based on Exelon common stock upon board service termination
Key Terms
Deferred phantom share equivalents, restricted stock unit (RSU), Exelon Long-term Incentive Plan (LTIP), non-qualified deferred compensation plan
4 terms
restricted stock unit (RSU) financial
"Annual restricted stock unit (RSU) award subject to the Exelon Long-term Incentive Plan"
A restricted stock unit (RSU) is a promise from a company to give an employee company shares (or cash equal to their value) at a future date if certain conditions are met, such as staying with the company or hitting performance targets. For investors, RSUs matter because when they convert into actual shares they increase the number of shares available and can create selling pressure as employees cash out—think of them as a future paycheck paid in company stock.
Exelon Long-term Incentive Plan (LTIP) financial
"subject to the Exelon Long-term Incentive Plan (LTIP) will fully vest"
non-qualified deferred compensation plan financial
"part of a multi-fund, non-qualified deferred compensation plan"
An arrangement where an employer agrees to pay part of an employee’s salary or bonus at a later date, often to attract or keep key staff. Think of it as a company IOU or a delayed paycheck held on the company’s books rather than in a protected retirement account; investors care because these promises create future cash obligations that are typically unsecured and depend on the company’s financial health, affecting risk, liabilities, and cash-flow planning.
FAQ
What did Exelon (EXC) director Marjorie Rodgers report in this Form 4 filing?
Marjorie Rodgers reported an annual grant of 3,720 restricted stock units and her existing deferred phantom share equivalents. The filing reflects routine director compensation rather than open-market trading activity in Exelon common stock.
How many restricted stock units did Exelon (EXC) grant to director Marjorie Rodgers?
Exelon granted Marjorie Rodgers 3,720 "2026 Directors Restricted Stock Units". These units vest and are settled in Exelon common stock on a 1-for-1 basis, with additional units accruing through dividend reinvestment until vesting.
When will Marjorie Rodgers’ 2026 Exelon (EXC) director RSUs vest and settle?
The 3,720 2026 director restricted stock units granted to Marjorie Rodgers will fully vest and be settled in Exelon common stock on a 1-for-1 basis on April 28, 2027, according to the filing’s footnote.
Does this Exelon (EXC) Form 4 show any open-market stock purchases or sales by Marjorie Rodgers?
No, the Form 4 does not show open-market purchases or sales. It reports a grant of 3,720 restricted stock units as compensation and a holding entry for 10,013 deferred phantom share equivalents within a deferred compensation plan.